BioLargo at "apex of opportunity" as it sees strong engineering division growth in 3Q – Proactive Investors USA & Canada

BioLargo Inc CEO Dennis Calvert tells Proactive it saw a jump in consolidated revenue during its third quarter. The company generated $712,000 in revenue, a 7% year-over-year increase. Revenue for its engineering division increased by 73% year-over-year and 92% month-over-month. Its net loss during the quarter was reduced to $1.3 million, down from $2.1 million in the year-ago period.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

See the article here:

BioLargo at "apex of opportunity" as it sees strong engineering division growth in 3Q - Proactive Investors USA & Canada

Related Post

Comments are closed.